Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) Equity Ratio: 2023-2025

Historic Equity Ratio for Camp4 Therapeutics (CAMP) over the last 1 years, with Sep 2025 value amounting to 0.68.

  • Camp4 Therapeutics' Equity Ratio rose 109.13% to 0.68 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.68, marking a year-over-year increase of 109.13%. This contributed to the annual value of 0.81 for FY2024, which is 135.81% up from last year.
  • According to the latest figures from Q3 2025, Camp4 Therapeutics' Equity Ratio is 0.68, which was down 12.93% from 0.78 recorded in Q2 2025.
  • Camp4 Therapeutics' 5-year Equity Ratio high stood at 0.82 for Q1 2025, and its period low was -7.44 during Q3 2024.
  • In the last 3 years, Camp4 Therapeutics' Equity Ratio had a median value of 0.73 in 2025 and averaged -1.10.
  • Data for Camp4 Therapeutics' Equity Ratio shows a peak YoY spiked of 135.81% (in 2024) over the last 5 years.
  • Over the past 3 years, Camp4 Therapeutics' Equity Ratio (Quarterly) stood at -2.25 in 2023, then soared by 135.81% to 0.81 in 2024, then skyrocketed by 109.13% to 0.68 in 2025.
  • Its Equity Ratio stands at 0.68 for Q3 2025, versus 0.78 for Q2 2025 and 0.82 for Q1 2025.